학술논문
'학술논문'
에서 검색결과 353건 | 목록
1~10
Academic Journal
Fléchon L; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Arib I; Department of Hematology, Lille Hospital, Lille, France.; Dutta AK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Hasan Bou Issa L; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Sklavenitis-Pistofidis R; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Tilmont R; Department of Hematology, Lille Hospital, Lille, France.; Stewart C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Dubois R; Department of Pathology, Lille Hospital, Lille, France.; Poulain S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France.; Copin MC; Department of Pathology, Angers University, Angers Hospital, INSERM, CRCI2NA, Angers, France.; Javed S; Department of Medical Oncology, Valenciennes Hospital, Valenciennes, France.; Nudel M; Department of Hematology, Lille Hospital, Lille, France.; Cavalieri D; Department of Hematology, Lille Hospital, Lille, France.; Escure G; Department of Hematology, Lille Hospital, Lille, France.; Gower N; Department of Hematology, Lille Hospital, Lille, France.; Chauvet P; Department of Hematology, Lille Hospital, Lille, France.; Gazeau N; Department of Hematology, Lille Hospital, Lille, France.; Saade C; Department of Hematology, Lille Hospital, Lille, France.; Thiam MB; Department of Hematology, Lille Hospital, Lille, France.; Ouelkite-Oumouchal A; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Gaggero S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Cailliau É; Department of Biostatistics, Lille Hospital, Lille, France.; Faiz S; Department of Pathology and Dermatology, Lille Hospital, Lille, France.; Carpentier O; Department of Pathology and Dermatology, Lille Hospital, Lille, France.; Duployez N; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France.; Idziorek T; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Mortier L; Department of Pathology and Dermatology, Lille Hospital, Lille, France.; OncoThai unit, INSERM UMR-S1189, Lille University, Lille, France.; Figeac M; Lille University, Lille Hospital, CNRS, INSERM, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France.; Preudhomme C; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Biology and Pathology Center, Lille Hospital, Lille, France.; Quesnel B; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Lille Hospital, Lille, France.; Mitra S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Morschhauser F; Department of Hematology, Lille Hospital, Lille, France.; Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Ghobrial IM; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Harvard Medical School, Boston, MA.; Harvard Medical School, Boston, MA.; Manier S; Canther, ONCOLille, INSERM UMR-S1277, CNRS UMR9020, Lille University, Lille, France.; Department of Hematology, Lille Hospital, Lille, France.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
O'Donnell EK; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address: Elizabeth_odonnell@dfci.harvard.edu.; Borden BA; Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.; Ghobrial IM; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE
Academic Journal
Izzo F; New York Genome Center, New York, NY, USA. franco.izzo@mssm.edu.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. franco.izzo@mssm.edu.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. franco.izzo@mssm.edu.; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA. franco.izzo@mssm.edu.; Myers RM; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Ganesan S; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Mekerishvili L; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Physiology, Biophysics and Systems Biology Graduate Program, Weill Cornell Medicine, New York, NY, USA.; Kottapalli S; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Prieto T; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Eton EO; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Tri-Institutional MD-PhD Program, Weill Cornell Medicine, Rockefeller University, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Botella T; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Dunbar AJ; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Bowman RL; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Sotelo J; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Potenski C; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Mimitou EP; New York Genome Center, New York, NY, USA.; Immunai, New York, NY, USA.; Stahl M; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.; El Ghaity-Beckley S; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Arandela J; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Raviram R; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Choi DC; Laboratory of Molecular Hematopoiesis, Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.; Richard T. Silver MD Myeloproliferative Neoplasm Center, Weill Cornell Medicine, New York, NY, USA.; Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Hoffman R; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Chaligné R; New York Genome Center, New York, NY, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; SAIL: Single-cell Analytics Innovation Lab, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Abdel-Wahab O; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Smibert P; New York Genome Center, New York, NY, USA.; 10x Genomics, Pleasanton, CA, USA.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Scandura JM; Laboratory of Molecular Hematopoiesis, Hematology and Oncology, Weill Cornell Medicine, New York, NY, USA.; Richard T. Silver MD Myeloproliferative Neoplasm Center, Weill Cornell Medicine, New York, NY, USA.; Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Marcellino B; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Levine RL; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Landau DA; New York Genome Center, New York, NY, USA. dlandau@nygenome.org.; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Academic Journal
Ghobrial IM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Gormley N; Division of Hematology, Food and Drug Administration, Silver Spring, Maryland.; Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), CIBER-ONC number CB16/12/00233, Salamanca, Spain.; Bergsagel PL; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Chesi M; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Dhodapkar MV; Winship Cancer Institute of Emory University, Atlanta, Georgia.; Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.; Fonseca R; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona.; Getz G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.; Kristinsson SY; Faculty of Medicine, University of Iceland, Reykjavík, Iceland.; Martinez-Climent JA; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; Manier S; Hematology Department, CHU Lille, Lille University, INSERM UMR-S1277, Lille, France.; Marinac CR; Dana-Farber Cancer Institute, Boston, Massachusetts.; Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.; Morgan GJ; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.; Davies FE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, New York.; Nadeem O; Dana-Farber Cancer Institute, Boston, Massachusetts.; Nuvolone M; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.; O'Donnell E; Dana-Farber Cancer Institute, Boston, Massachusetts.; Prosper F; Hematology Service and Cell Therapy Unit and Program of Hematology-Oncology CIMA, Clinica Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN) and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.; Centro de Investigación Biomedica en Red Cancer (CIBERONC) and RICORS TERAV, Madrid, Spain.; Shah UA; Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sperling AS; Dana-Farber Cancer Institute, Boston, Massachusetts.; Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.; Munshi NC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Castle PE; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.; Anderson KC; Dana-Farber Cancer Institute, Boston, Massachusetts.; San Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE
Nadeem O; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Aranha MP; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Redd R; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Timonian M; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Magidson S; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lightbody ED; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Alberge JB; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Bertamini L; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dutta AK; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; El-Khoury H; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bustoros M; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology and Medical Oncology, Meyer Cancer Center, New York-Presbyterian Hospital, New York, New York, USA.; Laubach JP; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bianchi G; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; O'Donnell E; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wu T; Broad Institute, Boston, MA, USA.; Tsuji J; Broad Institute, Boston, MA, USA.; Anderson K; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Getz G; Broad Institute, Boston, MA, USA.; Trippa L; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Richardson PG; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sklavenitis-Pistofidis R; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute, Boston, MA, USA.; Ghobrial IM; Center for Early Detection and Interception of Blood Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE
Academic Journal
Lee DJ; Department of Medicine, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; El-Khoury H; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Tramontano AC; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Alberge JB; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Davis MI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Redd R; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.; Sakrikar D; The Binding Site Inc, Rochester, MN.; Barnidge D; The Binding Site Inc, Rochester, MN.; Perkins MC; The Binding Site Group Ltd, Birmingham, United Kingdom.; Harding S; The Binding Site Group Ltd, Birmingham, United Kingdom.; Mucci L; Harvard T.H. Chan School of Public Health, Boston, MA.; Rebbeck TR; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Harvard T.H. Chan School of Public Health, Boston, MA.; Ghobrial IM; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Marinac CR; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
Lee DJ; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; O'Donnell EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, United States.; Raje N; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Panaroni C; Department of Medicine, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Redd R; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States.; Ligibel J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Sears DD; College of Health Solutions, Arizona State University, Phoenix, AZ, United States.; Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, United States.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, United States.; Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, United States.
Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Print ISSN: 1929-0748 (Print) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: PubMed not MEDLINE
Academic Journal
Hasan Bou Issa L; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Fléchon L; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Laine W; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Ouelkdite A; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Gaggero S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Cozzani A; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Tilmont R; Department of Hematology, CHU Lille, 59000 Lille, France.; Chauvet P; Department of Hematology, CHU Lille, 59000 Lille, France.; Gower N; Department of Hematology, CHU Lille, 59000 Lille, France.; Sklavenitis-Pistofidis R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Brinster C; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Thuru X; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Touil Y; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Quesnel B; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Department of Hematology, CHU Lille, 59000 Lille, France.; Mitra S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Ghobrial IM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Kluza J; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Manier S; Canther, INSERM UMR-S1277 and CNRS UMR9020, Lille University, 59000 Lille, France.; Department of Hematology, CHU Lille, 59000 Lille, France.
Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Roccaro AM; Sacco A; Jia X; Banwait R; Maiso P; Azab F; Flores L; Manier S; Kareem Azab A; Ghobrial IM
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: PubMed not MEDLINE; MEDLINE
Huston A; Leleu X; Jia X; Moreau AS; Ngo HT; Runnels J; Anderson J; Alsayed Y; Roccaro A; Vallet S; Hatjiharissi E; Tai YT; Sportelli P; Munshi N; Richardson P; Hideshima T; Roodman DG; Anderson KC; Ghobrial IM
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: PubMed not MEDLINE; MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Ghobrial IM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어